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Pneumococcal resistance to antimicrobial agents has 
shown a steady worldwide increase over recent decades 
[ 11. Penicillin-resistant pineumococci were first 
reported from Australia in 1967 [2] and became 
widespread over the 1980s and 1990s [3-51. The rapid 
increase of pneumococcal resistance raises concerns 
about options for adequate therapy of patients with 
systemic pneumococcal infections. Treatment failures 
in patients with penicillin-resistant or cephalosporin- 
resistant strains have been described [6-91. We have 
performed a prospective 5-~year surveillance study of 
pneumococcal resistance in a large southwestern 
German community hospital. Minimal inhibitory 
concentrations (MICs) were determined by the Etest 
which has proven to be a reliable alternative to con- 
ventional methods for antimicrobial susceptibility 
testing of pneumococci [ 10--131. 
Five hundred and fifty-four primary clinical 
isolates of pneumococci collected from hospitalized 
patients between September I992 and March 1998 
were used for the study. Four hundred and thirty of the 
pneumococcal strains were isolated from adults, and 
124 from children. The susceptibilities of pneumo- 
coccal strains to penicillin, ceftriaxone, erythromycin 
and rifampicin were determined by the Etest. MIC 
values were converted to categories of susceptibility by 
using the NCCLS standard M 100-S8 [14]. Table 1 
summarizes the data on MIC determinations in 
pneumococcal strains isolated from adults and children. 
The prevalence of isolates with intermediate or high- 
level resistance to penicillin (4.3%) or erythromycin 
(6.3%) in adults was lower than the corresponding 
prevalence of isolates resistant to penicillin (8.1%) or 
erythromicin (9.7%) in children. Pneumococcal strains 
with intermediate or high-level resistance to ceftriaxone 
were found only rarely. Strains resistant to rifampicin 
were not observed. Only one pneumococcal isolate 
from an adult patient demonstrated multiresistance 
(high-level resistance to penicillin and ceftriaxone and 
intermediate resistance to erythromycin). Resistance 
rates to penicillin remained remarkably constant over 
the 5-year surveillance period. Resistance rates to 
erythromycin, however, showed a more than threefold 
increase from 4.3% during winter 1993-1993 to 14.8% 
during winter 1997-98. 
Previous studies of the antibiotic susceptibility of 
pneumococci in Germany demonstrated that resistance 
rates to penicillin were 0.8% (strains collected between 
1980 and 1986) [15], 7.6% (strains collected between 
1988 and 1991) [16], and 1.8% (strains collected 
between 1992 and 1994 [17], respectively. The corres- 
ponding figures for resistance to erythromycin were 0% 
[15], 3.8% [16], and 3.8% [17]. A comparison of the 
reported data and our results shows that the prevalence 
of penicillin-resistant pneumococci had increased 
nearly 10-fold from the mid-1980s to the early 1990s; 
however, no further increase of resistance rates has been 
observed during recent years. Resistance of pneumo- 
cocci to erythromycin, however, which was absent in 
1986 [14], showed a steady increase throughout the 
1990s with a peak prevalence of about 15% during 
winter 1997-98. Thus our results demonstrate that, 
compared to other European and non-European 
regions, the situation regarding pneumococcal resist- 
ance to penicillin in Germany is still favorable. The 
occurrence of highly penicillin-resistant strains is 
extremely rare, and pneumococcal strains with multiple 
resistance to several antibiotics have been observed only 
occasionally. The recent increase of pneumococcal 
resistance to erythromycin, however, underlines the 
need for continuous surveillance of antimicrobial 
Table 1 Prevalence of antibiotic resistance in 554 clinical isolates of Streptococcus pneumoniae 
Intermediately 
Population Antimicrobial Susceptible strains resistant strains Highly resistant strains 
gi-oup agent (%) (W (%) 
Adults Penicillin G 412/430 ( 95.8) 17/430 (4.0) 1/430 (0.2) 
Children Penicillin G 114/124 ( 91.9) 10/124 (8.1) 0/124 (0) 
Adults Cehriaxone 428/43O ( 99.6) 11430 (0.2) 1/430 (0.2) 
Children Ceftriaxone 124/124 (100 ) 0/124 (0) 0/124 (0) 
Adults Erythromycin 4031430 ( 93.7) 6/430 (1.4) 211430 (4.9) 
Children Erythromycin ii2/124 ( 90.3) 0/124 (0) 12/124 (9.7) 
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susceptibility of Streptococcus pneumoniae as a guide to 
appropriate treatment of pneumococcal infections. 
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